Cargando…
Successfully treatment by eribulin in visceral crisis: a case of lymphangitic carcinomatosis from metastatic breast cancer
BACKGROUND: Metastatic breast cancer (MBC) rest an incurably disease associated with bad prognosis and a median overall survival of 23–31 months. There are several treatment options including chemotherapy and sometimes endocrine therapy. Currently, there is no standard treatment for patients with MB...
Autores principales: | Fumet, Jean-David, Wickre, Mark, Jacquot, Jean-Philippe, Bizollon, Marie-Helene, Melis, Adrien, Vanoli, André, Viel, Erika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102904/ https://www.ncbi.nlm.nih.gov/pubmed/30126360 http://dx.doi.org/10.1186/s12885-018-4725-7 |
Ejemplares similares
-
Lymphangitic Carcinomatosis of Possible Urothelial Origin
por: Saini, Tanjot, et al.
Publicado: (2023) -
Acute kidney injury associated with lymphangitic carcinomatosis
por: Sannier, Aurélie, et al.
Publicado: (2018) -
Pulmonary lymphangitic carcinomatosis secondary to ureteral cancer
por: Sugimoto, Hiroshi, et al.
Publicado: (2021) -
Pulmonary Lymphangitic Carcinomatosis due to Renal Cell Carcinoma
por: Guddati, Achuta K., et al.
Publicado: (2012) -
Relapsed breast adenorcarcinoma presenting as pulmonary lymphangitic carcinomatosis
por: Loh, KP, et al.
Publicado: (2012)